Boehringer Ingelheim is proud to announce the 2nd Boehringer Ingelheim IPVS Ileitis symposium during the IPVS 2006 congress in Copenhagen. The Symposium will take place on July 17 from 16.45h - 18.00h at the Congress Centre; Auditorium 15.
Boehringer Ingelheim Vetmedica, Inc., last week transferred ownership of its Risk Assessment Program for porcine reproductive and respiratory syndrome (PRRS) to the American Association of swine Veterinarians (AASV).
EU - Since the launch of Boehringer's ileitis vaccine "Enterisol® Ileitis" in most European countries from September to November 2005, the oral ileitis vaccine has very quickly become firmly established in health maintenance and performance enhancement in pig production.
Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve pig’s weight gain and to reduce body weight variability. From now on, Enterisol® Ileitis is available in 19 European countries.
Get the latest news on Swine Health Subscribe to our newsletter